key stock movers

Why Crinetics Pharmaceuticals Shares Are Trading Higher By 99%; Here Are 20 Stocks Moving Premarket

Crinetics and Vertex have entered into a definitive agreement under which Vertex will acquire Crinetics for $85 per share in cash, representing a total equity value of approximately $10 billion.

Crinetics Pharmaceuticals shares jumped 99.1% to $83.67 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

Losers

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.